Advanced SearchNewsfeedFollowed Companies

Taro's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Taro develops, manufactures and distributes generic pharmaceutical products in tablets, capsules, suspensions, solutions... Read more

Based on data from Taro's latest SEC filings

Annual Revenue

Based on data from Taro's latest SEC filings

Employees

Uday Baldota's photo - CEO of Taro

CEO

Uday Baldota

CEO Approval Rating

60/100

OVERVIEW

Founded:

1950

Headquarters:

HawthorneNew York

Status:

PublicSubsidiary of Sun Pharmaceutical Industries Ltd.NYSETARO

Industry Sector:

- -

SIC Code:

2834NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is TEVA Pharmaceuticals a competitor of Taro?

I don't know

Trending News for Taro and Taro's Competitors

February 20, 2020

MarketScreener

Taro Pharmaceutical Industries : Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5 mL Due to Possible Underdosing or Overdosing

(marketscreener.com) Taro Pharmaceuticals U.S.A., Inc. is voluntarily recalling two lots of Phenytoin... See more »

February 21, 2020

MarketScreener

Teva : Registration Trials in Tourette Syndrome Didn't Meet Primary Endpoint

(marketscreener.com) By Josh Beckerman Teva Pharmaceutical Industries Ltd. said registration trials t... See more »

February 21, 2020

Medical Buyer

Sanofi Ties Up With US For Virus Vaccine

MUMBAI: Sanofi Pasteur, the vaccine division of French pharma major Sanofi, on Wednesday said it will... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Mylan is Taro's top competitor. Mylan is headquartered in Canonsburg, Pennsylvania, and was founded in 1961. Mylan is in the Pharmaceuticals field. Mylan generates 1,002% the revenue of Taro.

Par Pharmaceutical is seen as one of Taro's top competitors. Par Pharmaceutical's headquarters is in Chestnut Ridge, New York, and was founded in 1978. Par Pharmaceutical competes in the Pharmaceuticals industry. Par Pharmaceutical generates 124% of Taro's revenue.

Lannett has been one of Taro's top competitors. Lannett was founded in 1942, and its headquarters is in Philadelphia, Pennsylvania. Lannett competes in the Pharmaceuticals field. Lannett has 387 fewer employees than Taro.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Uday Baldota

CEO

- -
1,407
$0
$1.1B
1

Heather Bresch

CEO

72/100
35,000
$7.9B
$11.4B
2

Tony Pera

President

67/100
1,600
- -
$1B
3

Timothy C. Crew

CEO

68/100
1,020
$532M
$570.1M
4

Kaare Schultz

President & CEO

72/100
42,535
$7.7B
$17.5B
5

Richard Saynor

CEO

66/100
26,500
- -
$9.9B
6

Paul Hudson

CEO

76/100
106,859
- -
$41.7B
7

Mark Trudeau

President & CEO

77/100
3,700
- -
$3.2B
8

Albert Bourla

CEO

68/100
92,400
- -
$53B
9

Umang Vohra

CEO

67/100
12,235
- -
$1.9B
10

Severin Schwan

CEO

64/100
3,700
- -
$927.4M
The top 10 competitors in Taro's competitive set are Mylan, Par Pharmaceutical, Lannett, TEVA Pharmaceuticals, Sandoz, Sanofi, Mallinckrodt, Pfizer, Cipla and Roche. Together they have raised over 16.0B between their estimated 412.9K employees. Taro has 1,407 employees and is ranked 10th among it's top 10 competitors. The top 10 competitors average 29,723.

Quarterly and Annual Revenue

Coming soon for Taro!

Annual Revenue

$1.1B

Taro's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 12.9B.

Acquisitions

No recent acquisitions found related to Taro

Investments

No recent investments found related to Taro

Taro News

February 4, 2020Seeking Alpha

Taro down 4% after FQ3 report, continued sales headwinds

See more »
February 4, 2020BioPortfolio

STAT Plus A former Taro Pharma executive is indicted in generic pricefixing probe

Such lawsuits detailed how companies would agree to divide a market rather than compete by lowering p... See more »
January 14, 2020Beckers Hospital Review

Taro Pharmaceuticals recalls epilepsy drug

See more »
January 13, 2020BioPortfolio

Taro Pharmaceutical Industries Ltd TARO Financial and Strategic SWOT Analysis Review Published by Global Data Prices from USD $106

Taro Pharmaceutical Industries Ltd TARO Financial and Strategic SWOT Analysis Review provides you an ... See more »
January 7, 2020Drug Store News

FeverAll Infants' Strength hits Publix stores

The Publix launch follows the product being added to Target stores, and executives from Taro attribut... See more »
December 20, 2019BioPortfolio

Taro Announces Final Results of Its Tender Offer

Taro Pharmaceutical Industries Ltd. NYSETARO Taro or the Company today announced the final results of... See more »
December 6, 2019BioPortfolio

Taro Announces Resignation of Chief Financial Officer

Taro Pharmaceutical Industries Ltd. NYSE TARO Taro or the Company announced today that it has accepte... See more »

Taro Press Releases

December 24, 2016NPR

Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc

Business Wire India Taro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") announc... See more »
December 19, 2016Blackbird

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Taro Pharmaceutical Industries Ltd. To Contact The Firm Before Imminent Lead Plaintiff Deadline

NEW YORK, Dec. 19, 2016 (GLOBE NEWSWIRE) - Faruqi & Faruqi, LLP, a leading national securities law fi... See more »
December 7, 2016Blackbird

Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Taro Pharmaceutical Industries Ltd. Investors and Encourages Investors to Contact the Firm

LOS ANGELES-(BUSINESS WIRE)-Glancy Prongay & Murray LLP ("GPM") announces that a class action lawsuit... See more »
June 22, 2016Business Wire India

Taro Announces Resignation of Chief Financial Officer

Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") announc... See more »
February 10, 2016PR Newswire

Kamedis and Taro Announce Availability of the Kamedis® Bio-Herbal Dandruff Care System at Walgreens

TEL AVIV, Israel, Feb. 10, 2016 /PRNewswire/ -- Kamedis Inc., a global provider of clinically proven ... See more »
February 5, 2016Business Wire India

CORRECTING and REPLACING Taro to Announce Third Quarter Results on February 10, 2016

Business Wire IndiaThe date at the end of the first paragraph of release dated February 2, 2016 shoul... See more »
November 4, 2015BUSINESS WIRE INDIA

Taro Provides Results for September 30, 2015

Business Wire IndiaTaro Pharmaceutical Industries Ltd. (NYSE:TARO) ("Taro" or the "Company") today ..... See more »

Headquarters

3 Skyline Drive Suite 120

Hawthorne, New York10532

866-923-4914

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Taro develops, manufactures and distributes generic pharmaceutical products in tablets, capsules, suspensions, solutions, creams and ointments. Taro was founded in 1950. Taro's headquarters is located in Hawthorne, New York, USA 10532. Taro's CEO, Ud...

CEO

Taro's CEO, Uday Baldota, currently has an approval rating of 60%. Taro's primary competitors are Mylan, Par Pharmaceutical & Lannett.

Website

taro.com

Frequently Asked Questions about Taro

  1. When was Taro founded?

    Taro was founded in 1950

  2. Who is Taro's CEO?

    Taro's CEO is Uday Baldota

  3. How much revenue does Taro generate?

    Taro generates $1.1B in revenue

  4. How much funding does Taro have?

    Taro has historically raised $0 in funding

  1. Where is Taro's headquarters?

    Taro's headquarters is in Hawthorne New York, USA

  2. How many employees does Taro have?

    Taro has 1,407 employees

  3. Who are Taro's competitors?

    Taro's top competitors are Mylan, Par Pharmaceutical, Lannett
Stay up-to-date with the latest news on Taro